Figure 5.

Prescription of disease-modifying anti-rheumatic drugs in patients with different anti-cyclic citrullinated peptide status. Diagram to illustrate the prescription of disease-modifying anti-rheumatic drugs (DMARDs) at different time points after enrolment of patients with different anti-cyclic citrullinated peptide (aCCP) status. Prescribing physicians were unaware of the aCCP results.